Clinical Research Platform into Molecular Testing, Treatment, Outcome (CRISP): A Prospective German Registry in Stage IV NSCLC AIO-TRK-0315. 8. Juni 2017 Griesinger, F., Eberhardt, W., Marschner, N., Jänicke, M., Hipper, A., Karatas, A., Sebastian, M., Thomas, M., Schirmacher, P., 2017. J Thorac Oncol 12(1)(MA08.02), S385. doi:10.1016/j.jtho.2016.11.435 Abstract Dermatux: phase IV trial of Cetuximab plus FOLFIRI in first-line metastatic colorectal cancer receiving a pre-defined skin care. Schimanski, C.C., Staib, F., Göhler, T., Hebart, H., Heike, M., Neise, M., Rudi, J., Geer, T., Dingeldein, G., Lang, C., Ehscheidt, P., Flohr, T., Josten,… Weiterlesen Treatment and pattern of bone metastases in 1094 patients with advanced breast cancer – Results from the prospective German Tumour Registry Breast Cancer cohort study. Schröder, J., Fietz, T., Köhler, A., Petersen, V., Tesch, H., Spring, L., Fleitz, A., Jänicke, M., Marschner, N., 2017. Eur J Cancer 79, 139–148. doi:10.1016/j.ejca.2017.03.031… Weiterlesen